Since last year, DexCom ( DXCM +5.54%) has faced a series of issues that have sunk its stock price. The medical device ...

According to Diabète Québec, type 2 diabetes is the most common form, affecting nearly 90% of those living with diabetes, and many eventually require insulin when lifestyle changes and oral ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...

Shares of DexCom Inc. slipped 5.21% to $55.00 Friday, on what proved to be an all-around favorable trading session for the ...

Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...

The CGM market is expected to experience double-digit percentage growth over the next five years, reaching nearly $29 billion ...

It's rare for an attractive dividend stock also to have growth potential. Most leading dividend distributors have moved past ...

The global patient monitoring devices market size is expected to reach USD 118.21 billion by 2033, registering a CAGR of 10.21% from 2025 to 2033, according to a new report by Grand View Research, Inc ...

Tracking insider buying and selling can provide valuable insights for investors. When company executives, directors, or major shareholders invest their own money in their company’s stock, it may ...

Synchron Inc. raised $200 million to advance its work building brain implants that doctors can insert through blood vessels, ...

Levi & Korsinsky, LLP notifies investors in DexCom, Inc. (NASDAQ: DXCM) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DexCom, Inc. investors ...

Memory and data storage stocks led the tech sector higher Monday amid optimism about growing AI-driven demand.